Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02817022
Other study ID # Developmental supportive care
Secondary ID
Status Recruiting
Phase N/A
First received April 29, 2016
Last updated June 24, 2016
Start date January 2016
Est. completion date June 2017

Study information

Verified date June 2016
Source Lady Hardinge Medical College
Contact VIKRAM DATTA, MD,DNB
Phone 91-1123344151
Email drvikramdatta@gmail.com
Is FDA regulated No
Health authority India: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Enrolled neonates will be provided routine supportive care as per existing neonatal intensive care unit (NICU)protocols. This will be carried out in the initial 6 months (0-180 days) of study commencement. This group will serve as control group (group A). During subsequent 6 months (181-360 days) of the study period, enrolled neonates fulfilling the inclusion criteria will be provided routine supportive care and the components of developmentally supportive care (DSC).


Description:

Enrolled neonates will be provided routine supportive care as per existing NICU protocols. This will be carried out in the initial 6 months (0-180 days) of study commencement. This group will serve as control group (group A). During subsequent 6 months (181-360 days) of the study period, enrolled neonates fulfilling the inclusion criteria will be provided routine supportive care and the components of developmentally supportive care (DSC). DSC components will be strictly emphasized on protected sleep, pain and stress assessment and management, activities of daily living (positioning, feeding and skin care), the healing environment. This group will be designated as group B. Both the groups will receive appropriate management for their morbidities as per existing NICU protocols. Both the groups will be followed up till 37 weeks of gestation where in their neurobehavioral assessment will be performed using Neurobehavioural assessment of preterm infants score.

In both the groups all the baseline data regarding antenatal factors will be recorded in a predesigned proforma such as age, gravid, Gestational age, Chorioamnionitis, Prenatal steroids, Multiple pregnancy, maternal comorbidities (preeclampsia, gestational diabetes mellitus), mode of delivery etc.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date June 2017
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender Both
Age group N/A to 37 Weeks
Eligibility Inclusion Criteria:

- All stable preterm very low birth weight babies not on invasive mechanical ventilation

- Hemodynamically stable

- Parental consent

Exclusion Criteria:

- Babies with major congenital anomalies

- Asphyxia (Apgar score <3 at 5mins).

- Acute bilirubin encephalopathy

- Hypoglycemia at enrollment

- Clinical Chorioamnionitis(fever > 100.4 ? f , uterine fundal tenderness, maternal tachycardia (>100/min), fetal tachycardia (>160/min) and purulent or foul amniotic fluid )

- History of birth trauma

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
developmentally supportive care
DSC components will be strictly emphasized on protected sleep, pain and stress assessment and management, activities of daily living (positioning, feeding and skin care), the healing environment

Locations

Country Name City State
India Lady Hardinge Medical College,New Delhi Delhi
India Lady Hardinge Medical College New Delhi Delhi

Sponsors (1)

Lead Sponsor Collaborator
Lady Hardinge Medical College

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of apneic episodes during hospital stay will be measured as per standard definition of neonatal apnea and expressed as numbers. 18 months No
Other IVH Grade 2 or more will be measured using bedside cranial sonogram and classified using Volpe's classification. 18 months No
Other BPD Presence or absence will be noted and mentioned as yes or no. 18 months No
Other NEC Stage 2 or more Will be staged using Bells staging . 18 months No
Other ROP (any stage) Will be graded using standard classification . 18 months No
Primary Neurobehavioral outcome Of the Preterm Very low birth weight babies Neurobehavioural outcome will be measured by NAPI at 37 weeks of corrected gestational age. 18 months No
Secondary Time to achieve full feeds @150ml/kg Time to achieve full feed @150 ml/kg/day will be measured in days. 18 months No
Secondary Length of hospital stay will be measured in days 18 months No
See also
  Status Clinical Trial Phase
Recruiting NCT03896893 - Neonatal Bacterial Colonization Study N/A
Completed NCT01350765 - Naushero Feroze Neonatal Survival Project N/A
Completed NCT03403530 - Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates Phase 4
Completed NCT01360528 - Serum Folic Acid Levels in Preterm Infants N/A
Completed NCT06379178 - Effect of Oral Colostrum Applications Every 2 Hours and 4 Hours In Order to Achieve Trophic Feeding in Preterm Infants N/A
Completed NCT01335490 - Intervening to Improve Infant Health in Ghana N/A
Completed NCT03214822 - Human-derived Human Milk Fortifiers (H2MF), Gut Microbiota and Oxidative Stress in Premature Infants N/A
Completed NCT01220687 - Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation N/A